NL9002779A - Viraal middel. - Google Patents

Viraal middel. Download PDF

Info

Publication number
NL9002779A
NL9002779A NL9002779A NL9002779A NL9002779A NL 9002779 A NL9002779 A NL 9002779A NL 9002779 A NL9002779 A NL 9002779A NL 9002779 A NL9002779 A NL 9002779A NL 9002779 A NL9002779 A NL 9002779A
Authority
NL
Netherlands
Prior art keywords
ala
leu
gly
ser
pro
Prior art date
Application number
NL9002779A
Other languages
English (en)
Dutch (nl)
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898928562A external-priority patent/GB8928562D0/en
Priority claimed from GB909004414A external-priority patent/GB9004414D0/en
Priority claimed from GB909004814A external-priority patent/GB9004814D0/en
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of NL9002779A publication Critical patent/NL9002779A/nl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1081Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
    • C07K16/109Hepatitis C virus; Hepatitis G virus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • C12Q1/706Specific hybridization probes for hepatitis
    • C12Q1/707Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/24011Flaviviridae
    • C12N2770/24211Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82Proteins from microorganisms
    • Y10S530/826Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NL9002779A 1989-12-18 1990-12-17 Viraal middel. NL9002779A (nl)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB898928562A GB8928562D0 (en) 1989-12-18 1989-12-18 Viral agent
GB8928562 1989-12-18
GB909004414A GB9004414D0 (en) 1990-02-27 1990-02-27 Viral agent
GB9004414 1990-02-27
GB909004814A GB9004814D0 (en) 1990-03-03 1990-03-03 Viral agent
GB9004814 1990-03-03

Publications (1)

Publication Number Publication Date
NL9002779A true NL9002779A (nl) 1991-07-16

Family

ID=27264852

Family Applications (1)

Application Number Title Priority Date Filing Date
NL9002779A NL9002779A (nl) 1989-12-18 1990-12-17 Viraal middel.

Country Status (24)

Country Link
US (1) US6210675B1 (sv)
JP (1) JPH06107687A (sv)
AR (1) AR243239A1 (sv)
AT (1) AT400724B (sv)
AU (1) AU642942B2 (sv)
BE (1) BE1005485A5 (sv)
BR (1) BR9006422A (sv)
CA (1) CA2032381C (sv)
CH (1) CH684594A5 (sv)
DE (1) DE4040339C2 (sv)
DK (1) DK298190A (sv)
ES (1) ES2029171A6 (sv)
FI (1) FI906208A (sv)
FR (1) FR2655990A1 (sv)
GB (1) GB2239245B (sv)
GR (1) GR1001261B (sv)
HU (1) HUT56883A (sv)
IE (1) IE65172B1 (sv)
IT (1) IT1242183B (sv)
LU (1) LU87861A1 (sv)
NL (1) NL9002779A (sv)
NO (1) NO905438L (sv)
NZ (1) NZ236491A (sv)
SE (1) SE9004010A (sv)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5698390A (en) * 1987-11-18 1997-12-16 Chiron Corporation Hepatitis C immunoassays
US5712088A (en) * 1987-11-18 1998-01-27 Chiron Corporation Methods for detecting Hepatitis C virus using polynucleotides specific for same
US5683864A (en) * 1987-11-18 1997-11-04 Chiron Corporation Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies
US6861212B1 (en) 1987-11-18 2005-03-01 Chiron Corporation NANBV diagnostics and vaccines
US6171782B1 (en) 1987-11-18 2001-01-09 Chiron Corporation Antibody compositions to HCV and uses thereof
US5350671A (en) * 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
US5714596A (en) * 1987-11-18 1998-02-03 Chiron Corporation NANBV diagnostics: polynucleotides useful for screening for hepatitis C virus
US6027729A (en) * 1989-04-20 2000-02-22 Chiron Corporation NANBV Diagnostics and vaccines
US5372928A (en) * 1989-09-15 1994-12-13 Chiron Corporation Hepatitis C virus isolates
US5712087A (en) * 1990-04-04 1998-01-27 Chiron Corporation Immunoassays for anti-HCV antibodies employing combinations of hepatitis C virus (HCV) antigens
WO1991015771A1 (en) * 1990-04-04 1991-10-17 Chiron Corporation Combinations of hepatitis c virus (hcv) antigens for use in immunoassays for anti-hcv antibodies
ATE194844T1 (de) * 1990-04-06 2000-08-15 Genelabs Tech Inc Hepatitis c-virus-epitope
JP3549201B2 (ja) * 1990-10-24 2004-08-04 中外製薬株式会社 非a非b型肝炎特異的遺伝子の検出方法及び検出用試薬組成物
EP0485209A1 (en) * 1990-11-08 1992-05-13 Immuno Japan Inc. Non A, non B hepatitis virus related antigen, antibody detection systems, polynucleotides and polypeptides
KR920703640A (ko) * 1990-11-29 1992-12-18 테루카츄 아리마 비a비b형 간염 바이러스 항원 단백질
US6190864B1 (en) 1991-05-08 2001-02-20 Chiron Corporation HCV genomic sequences for diagnostics and therapeutics
JPH06508026A (ja) * 1991-05-08 1994-09-14 カイロン コーポレイション 診断と治療に用いるhcvゲノム配列
DE69232871T2 (de) * 1991-06-24 2003-05-08 Chiron Corp Polypeptide des hepatitis c-virus (hiv)
WO1993002193A1 (es) * 1991-07-19 1993-02-04 Bartolome Nebreda Fernando Jav cDNAS DERIVADOS DEL VIRUS C DE LA HEPATITIS
PT787807E (pt) * 1991-08-27 2003-08-29 Hoffmann La Roche Iniciadores e sondas para a deteccao da hepatite c
GB9203803D0 (en) * 1992-02-21 1992-04-08 Wellcome Found A recombinant polypeptide
UA39944C2 (uk) * 1992-07-07 2001-07-16 Чірон Корпорейшн Спосіб визначення ранньої сероконверсії у ссавця-хазяїна до вірусу гепатиту с і набір для використання в способі
US6153378A (en) * 1992-10-16 2000-11-28 Bionova Corporation Diagnosis of, and vaccination against, a positive stranded RNA virus using an isolated, unprocessed polypeptide encoded by a substantially complete genome of such virus
US7255997B1 (en) 1993-04-27 2007-08-14 N.V. Innogenetics S.A. Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
ATE551423T1 (de) 1993-04-27 2012-04-15 Innogenetics Nv Sequenzen von hepatitis c virus-genotypen sowie ihre verwendungen als therapeutika und diagnostika
AU8003894A (en) * 1993-10-29 1995-05-22 Srl Inc. Antigen peptide compound and immunoassay method
PT804584E (pt) 1994-10-21 2002-11-29 Innogenetics Nv Sequencias de virus da hepatite c genotipo 7 e sua utilizacao como agentes profilacticos terapeuticos e de diagnostico
FR2775690B1 (fr) * 1998-03-09 2001-12-14 Bio Merieux Anticorps monoclonal et utilisations pour detecter des antigenes de la proteine core de vhc
US6071721A (en) * 1998-11-13 2000-06-06 Incyte Pharmaceuticals, Inc. Calcium binding protein
US7067313B1 (en) * 1999-07-14 2006-06-27 D. Collen Research Foundation Ligands for use in therapeutic compositions for the treatment of hemostasis disorders
US7829085B2 (en) * 1999-07-14 2010-11-09 Life Sciences Research Partners Vzw Methods of treating hemostasis disorders using antibodies binding the C1 domain of factor VIII
CU23244A1 (es) * 2001-07-16 2007-10-17 Ct Ingenieria Genetica Biotech Formulacion vacunal potenciada por la combinacion de un adn con un antigeno
US7196183B2 (en) 2001-08-31 2007-03-27 Innogenetics N.V. Hepatitis C virus genotype, and its use as prophylactic, therapeutic and diagnostic agent
PL209710B1 (pl) * 2002-09-09 2011-10-31 Chiron Corp Sposób wykrywania infekcji wirusem zapalenia wątroby typu C (HCV)
JP4422430B2 (ja) * 2003-05-14 2010-02-24 帝國製薬株式会社 エストロゲン及び/又はプロゲストゲン含有外用貼付剤
EP1706079B1 (en) * 2003-08-14 2013-02-20 ThromboGenics N.V. Antibodies against factor viii with modified glycosylation in the variable region
US8124747B2 (en) 2003-08-29 2012-02-28 Innogenetics HCV clade and prototype sequences thereof
EP2833900B1 (en) 2012-04-01 2018-09-19 Technion Research & Development Foundation Limited Extracellular matrix metalloproteinase inducer (emmprin) peptides and binding antibodies
US20210122819A1 (en) * 2018-01-18 2021-04-29 Adanate, Inc. Anti-lilrb antibodies and uses thereof

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4356164A (en) 1979-05-21 1982-10-26 Govt. of the U.S., as represented by the Secretary, Dept. of Health & Human Services Detection of non-A, non-B hepatitis associated antigen
US4464474A (en) * 1980-07-09 1984-08-07 Connaught Laboratories Limited Non-A, non-B hepatitis assay and vaccine
EP0071640B1 (en) 1981-02-11 1986-06-04 Connaught Laboratories Incorporated Non-a, non-b hepatitis virus
US4542016A (en) 1981-03-27 1985-09-17 Institut Merieux Non-a non-b hepatitis surface antigen useful for the preparation of vaccines and methods of use
JPS57198867A (en) 1981-06-02 1982-12-06 Eisai Co Ltd Non-a, non-b hepatitis related antigen and diagnostic therefor
JPS58183629A (ja) 1982-04-21 1983-10-26 Eisai Co Ltd 非a非b型肝炎関連モノクロナ−ル抗体および診断薬
US4702909A (en) * 1982-05-05 1987-10-27 Louisiana State University A & M Non-A, non-B hepatitis antigen, antigen compositions, vaccine and diagnostic reagent
US4707439A (en) 1984-10-26 1987-11-17 The United States Of America As Represented By The Department Of Health And Human Services Screening test for reverse-transcriptase containing virus such as non-A, non-B hepatitis, NANBH
GB8431171D0 (en) 1984-12-11 1985-01-23 Technology Licence Co Ltd Monoclonal antibodies
JPS61176856A (ja) 1985-02-01 1986-08-08 Mitsubishi Chem Ind Ltd 非a非b型肝炎抗原
US4673634A (en) 1985-03-08 1987-06-16 The United States Of America As Represented By The Department Of Health And Human Services Purified antigen from non-A, non-B hepatitis causing factor
FR2597606B1 (fr) 1986-04-16 1989-10-06 Pasteur Institut Nouveau reactif pour la detection d'hepatites virales non a non b et procede de diagnostic de telles hepatites par voie immunoenzymatique
JPS6391328A (ja) 1986-10-07 1988-04-22 Mitsubishi Kasei Corp 非a非b型肝炎抗原
NZ222465A (en) 1986-11-07 1992-11-25 Pasteur Institut Nanb (non a, non b hepatitis viral) antigen
US5141867A (en) * 1987-02-02 1992-08-25 E. I. Du Pont De Nemours And Company Nucleotide sequence encoding a human immunodeficiency virus antigen
DE3744242A1 (de) 1987-02-20 1989-07-06 Seelig Renate Virusantigen, verfahren zu seiner gewinnung und anwendung in diagnose und therapie (impfstoff)
US5032511A (en) * 1987-03-31 1991-07-16 Mitsubishi Kasei Corporation DNA fragments coding for antigens specific to non-A non-B hepatitis, expression vectors containing said DNA fragments, transformants and process for producing said antigens
HU220204B (hu) * 1987-11-18 2001-11-28 Chiron Corp. HCV polipeptidek és HCV polinukleotidok, ilyen polinukleotidokat tartalmazó vektorok és ezekkel transzformált gazdasejtek, valamint HCV fertőzés kimutatására szolgáló diagnosztikumok és immunvizsgálati készlet
GB2212511B (en) * 1987-11-18 1992-01-22 Chiron Corp Hepatitis c virus
AU624105B2 (en) * 1987-11-18 1992-06-04 Novartis Vaccines And Diagnostics, Inc. Nanbv diagnostics and vaccines
US5350671A (en) * 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
AU632271B2 (en) 1988-03-30 1992-12-24 Abbott Laboratories Production of monoclonal antibodies specific for non-a, non-b hepatitis infected liver
AU3748489A (en) 1988-06-17 1990-01-12 Genelabs Incorporated Enterically transmitted non-a/non-b hepatitis viral agent
JPH04501203A (ja) * 1988-07-06 1992-03-05 ジェネラブズ インコーポレイティド 後―輸血性,非―a,非―b型肝炎ウィルス及び抗原
IL91371A0 (en) 1988-08-24 1990-04-29 Us Commerce Clones or vectors bearing dna sequences of non-a and non-b hepatitis and a method for detecting these materials in blood
US5191064A (en) * 1988-09-30 1993-03-02 The Research Foundation For Microbial Diseases (Osaka University) Non-a, non-b hepatitis virus antigen peptide
JPH02167081A (ja) 1988-12-21 1990-06-27 Tetsuo Nakamura 非A非B型肝炎ウイルスゲノムRNA、cDNAおよびウイルス抗原蛋白質
WO1990011089A1 (en) * 1989-03-17 1990-10-04 Chiron Corporation Nanbv diagnostics and vaccines
DE69033891T2 (de) * 1989-05-18 2002-08-29 Chiron Corp NANBV-Diagnostika: Polynukleotide, geeignet für Reihenuntersuchungen auf Hepatitis C-Virus
EP0416725A3 (en) * 1989-07-14 1991-03-20 Chugai Seiyaku Kabushiki Kaisha Blood-borne non-a, non-b hepatitis specific protein, dna encoding it, and process for its production
ATE161041T1 (de) 1989-08-25 1997-12-15 Chiron Corp Verfahren zur hcv-züchtung in zell-linien aus b- oder t-lymphozyten
WO1991004262A1 (en) 1989-09-15 1991-04-04 National Institute Of Health Of Japan New hcv isolates
US5372928A (en) 1989-09-15 1994-12-13 Chiron Corporation Hepatitis C virus isolates
US5106726A (en) * 1990-02-16 1992-04-21 United Biomedical, Inc. Synthetic peptides specific for the detection of antibodies to HCV
WO1991015771A1 (en) 1990-04-04 1991-10-17 Chiron Corporation Combinations of hepatitis c virus (hcv) antigens for use in immunoassays for anti-hcv antibodies
EP0464287A1 (en) * 1990-06-25 1992-01-08 The Research Foundation for Microbial Diseases of Osaka University Non-A, non-B hepatitis virus genomic cDNA and antigen polypeptide

Also Published As

Publication number Publication date
GB2239245A (en) 1991-06-26
FR2655990A1 (fr) 1991-06-21
AT400724B (de) 1996-03-25
AR243239A1 (es) 1993-07-30
IE65172B1 (en) 1995-10-04
IT9048588A1 (it) 1991-06-19
FI906208A (fi) 1991-06-19
SE9004010L (sv) 1991-06-19
NO905438L (no) 1991-06-19
IT1242183B (it) 1994-02-16
NZ236491A (en) 1993-10-26
ATA257190A (de) 1995-07-15
IE904540A1 (en) 1991-06-19
BR9006422A (pt) 1991-09-24
CH684594A5 (fr) 1994-10-31
IT9048588A0 (it) 1990-12-17
GB9027250D0 (en) 1991-02-06
GB2239245B (en) 1993-11-10
JPH06107687A (ja) 1994-04-19
DE4040339C2 (de) 1999-07-08
LU87861A1 (fr) 1991-10-08
ES2029171A6 (es) 1992-07-16
DK298190A (da) 1991-06-19
SE9004010D0 (sv) 1990-12-17
DE4040339A1 (de) 1991-06-20
NO905438D0 (no) 1990-12-17
GR1001261B (el) 1993-06-30
FR2655990B1 (sv) 1995-04-07
AU642942B2 (en) 1993-11-04
DK298190D0 (da) 1990-12-17
US6210675B1 (en) 2001-04-03
GR900100868A (en) 1992-05-12
CA2032381C (en) 2006-02-21
FI906208A0 (fi) 1990-12-17
CA2032381A1 (en) 1991-06-19
BE1005485A5 (fr) 1993-08-10
HUT56883A (en) 1991-10-28
AU6817590A (en) 1991-06-20
HU908296D0 (en) 1991-06-28
SE9004010A (sv) 1991-06-19

Similar Documents

Publication Publication Date Title
US6210675B1 (en) PT-NANB hepatitis polypeptides
CA2065287C (en) New hcv isolates
US5871903A (en) HCV isolates
RU2155228C2 (ru) Hcv геномные последовательности для диагностических и терапевтических целей
EP0423239A1 (en) Post-transfusion, non-a, non-b hepatitis virus and antigens
US5218099A (en) Post-transfusion, non-A, non-B hepatitis virus polynucleotides
KR0178399B1 (ko) 장을 통해 전염되는 비a비b형 간염 바이러스 병원체 및 그것의 특유한 에피토프
JPH08504096A (ja) E型肝炎パキスタン株の組換えタンパク質ならびに診断法およびワクチンにおけるそれらの利用
JP4641695B2 (ja) 新規なhev抗原性ペプチド及び方法
CA2070952A1 (en) Gene of hepatitis c virus or fragment thereof, polypeptide encoded by the same
WO1995032290A2 (en) Non-a/non-b/non-c/non-d/non-e hepatitis agents and molecular cloning thereof
WO1993017110A2 (en) A recombinant hepatitis c virus polypeptide
WO1992009634A1 (en) Non-a non-b hepatitis virus antigen protein
US7166287B1 (en) Viral agent
WO2002089733A2 (en) Recombinant orf2 proteins of the swine hepatitis e virus and their use as a vaccine and as a diagnostic reagent for medical and veterinary applications
JPH06507552A (ja) 肝炎疾患の診断において有用なdna配列及びコードされたポリペプチド
AU3572593A (en) Hepatitis C virus peptides
AU5809694A (en) Peptides from the c33 region of hcv, antibodies thereto and methods for the detection of hcv
US20040176583A1 (en) Non-B, non-C, non-G hepatitis virus gene, polynucleotide, polypeptide, virus particle, method for isolating virus particle, and method for detecting virus
PL168925B1 (pl) Sposób wykrywania antygenu wirusowego PT-NANBH i przeciwciała przeciwko antygenowi wirusowemu PT-NANBH
PT96223B (pt) Processo para a preparacao de um agente viral responsavel pela hepatite nao-a bnao-b de pos-transfusao
CA2225318A1 (en) Diagnostic test for equine arteritis virus mediated disease

Legal Events

Date Code Title Description
BC A request for examination has been filed
BV The patent application has lapsed